AGL News and Press, agilon health inc. From 12/11/23

USE OF PARSORTIX SYSTEM IN PRE-CLINICAL MODEL UNLOCKS OPPORTUNITIES FOR DRUG DISCOVERY Harvested CTCs reveal gene expression profile associated with development and progression of brain metastasis in melanoma Researchers suggest such profiling could prove to be "pivotal" to prescribing m...

GUILDFORD, SURREY / ACCESSWIRE / December 11, 2023 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, is pleased to announce that Berenberg will ...

2023-11-30 18:07:37 ET More on agilon health agilon health: High Growth But Unsustainable Economics agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation agilon health hits 52-week low after guidance cut For further details see...

2023-11-21 14:23:55 ET More on agilon health agilon health: High Growth But Unsustainable Economics agilon health, inc. (AGL) Q3 2023 Earnings Call Transcript agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation agilon health ...

2023-11-20 09:18:54 ET Summary agilon health's full-year outlook caused its stock to fall sharply, raising concerns about the sustainability of its business model. While the company reported a 71% increase in revenue and a rise in Medicare Advantage membership, its gross profit gr...

2023-11-20 04:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIES ANGLE's Portrait PD-L1 test uses CTCs harvested from the Parsortix system to investigate real-time patient PD-L1 status for clinical studies The test is designed for highly accurate, repeatable, and precise results for CTC PD-L...

2023-11-05 19:51:03 ET Start Time: 16:30 End Time: 17:29 agilon health, inc. (AGL) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 PM ET Company Participants Steve Sell - CEO Tim Bensley - CFO Matthew Gillmor - VP, IR Conference Call Parti...

2023-11-03 12:25:59 ET More on agilon health agilon health: Improved Member Growth And Economies of Scale May Imply Undervaluation agilon health: Strong Sales Growth, Lacks Remaining Value Drivers agilon health announces sale of MDX Hawaii Seeking Alphaȁ...

2023-11-03 10:02:39 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: Cellectis, VYNE Therapeutics among healthcare movers